1 | 21/M | Yes | Yes | M3 | N/D | No | Tetraploidy | Yes | Death, relapse | 14 |
2 | 45/F | Yes | Yes | M2 | CD7/13/33+, HLA-DR− | No | Del (15)(q13q15) | Yes | Death, relapse | 15 |
3 | 4.5/M | No | No | M4/M5 | CD33+, HLA-DR+ | Yes | t(9;11)(p22;q23) | Yes | Remission 18+ months | 16 |
4 | 29/F | No | No | M2 | CD34/33+, CD13− | No | Diploid/ near triploid/ near tetraploid | No | Refractory death post allotransplant | 17 |
5 | 46/F | Yes | Yes | M4 | CD34/7/33+, CD13− | No | Diploid/ near tetraploid | Yes | Death, relapse | 17 |
6 | 29/F | Yes | Yes | M1 | N/A | No | Near triploid/ near tetraploid | Yes | Death, relapse | 17 |
7 | 34/F | No | No | M2 | CD33+, HLA-DR+ | Yes | -10, -11 | No | Death, refractory disease | 18 |
8 | 42/F | No | No | M0 | CD7/34/33+, CD13+ | No | 15, +19, +20 | Yes | Death, heart failure | 19 |
9 | 26/M | No | Yes | RAEB | CD33+ | Yes | Normal | N/A | Death, post chemo | 20 |
10 | 17/F | No | N/D | M1 | CD7/65/CD56+, HLA-DR+, CD13/33− | Yes | Near triploid/ near tetraploid | No | Death | This paper |